Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 11.52B | 0.75%12.98B | 3.57%53.27B | -0.56%13.27B | -5.79%12.88B | 10.53%51.43B | 1.83%13.07B | 7.80%11.35B | 17.55%13.34B | 15.65%13.67B |
| Cost of revenue | 999M | 1.68%908M | 22.85%4.08B | 30.73%1.11B | 18.44%893M | 25.22%3.32B | 15.51%864M | 21.51%853M | 40.07%846M | 26.72%754M |
| Gross profit | 10.52B | 0.68%12.07B | 2.24%49.19B | -2.68%12.16B | -7.20%11.99B | 9.64%48.11B | 0.98%12.21B | 6.82%10.49B | 16.29%12.49B | 15.06%12.92B |
| Operating expense | 6.61B | 2.79%7.84B | 19.62%40.26B | 38.71%11.57B | -16.49%7.63B | -3.08%33.66B | -19.14%9.15B | -9.22%7.03B | 6.38%8.34B | 16.74%9.14B |
| Staff costs | --1.29B | -2.54%1.27B | -3.13%5.14B | -16.34%1.08B | -5.38%1.3B | -2.71%5.31B | 30.61%1.49B | -18.15%1.16B | -14.16%1.29B | -1.86%1.38B |
| Selling and administrative expenses | --775M | -24.03%762M | 1.58%3.72B | -1.86%896M | 15.29%1B | 2.52%3.66B | -1.66%950M | 16.69%930M | 1.56%913M | -4.50%870M |
| -General and administrative expense | --775M | -24.03%762M | 1.58%3.72B | -1.86%896M | 15.29%1B | 2.52%3.66B | -1.66%950M | 16.69%930M | 1.56%913M | -4.50%870M |
| Depreciation and amortization | --774M | -9.25%755M | -8.89%3.24B | -10.11%818M | -8.07%832M | -5.78%3.55B | -6.72%861M | -8.46%877M | -3.09%910M | -4.84%905M |
| -Depreciation | --505M | -18.97%487M | -14.49%2.25B | -16.64%566M | -10.83%601M | -3.49%2.63B | -8.83%630M | -5.83%646M | 1.80%679M | -0.88%674M |
| -Amortization | --269M | 16.02%268M | 7.03%989M | 9.09%252M | 0.00%231M | -11.75%924M | -0.43%231M | -15.07%231M | -15.07%231M | -14.76%231M |
| Other operating expenses | --3.77B | 12.55%5.06B | 33.26%28.16B | 67.89%8.77B | -24.94%4.49B | -3.63%21.13B | -29.39%5.86B | -11.13%4.06B | 16.18%5.23B | 31.18%5.99B |
| Operating profit | 3.91B | -3.01%4.23B | -38.24%8.93B | -85.77%591M | 15.27%4.36B | 57.92%14.45B | 296.50%3.06B | 66.54%3.46B | 43.04%4.15B | 11.21%3.78B |
| Net non-operating interest income (expenses) | 0 | -6.25%-85M | -2,100.00%-80M | 50.00%6M | 0 | |||||
| Non-operating interest income | ---- | ---- | -83.33%1M | ---- | ---- | 50.00%6M | ---- | ---- | ---- | ---- |
| Total other finance cost | --0 | ---- | 0.00%86M | ---- | ---- | --86M | --0 | --0 | ---- | ---- |
| Net investment income | 115M | -533M | 77.27%39M | 112.43%22M | 68.34%-183M | 4,900.00%50M | -91.61%12M | -44.36%143M | ||
| Gain(Loss) on financial instruments designated as cash flow hedges | -133M | 24.69%-61M | -118.39%-190M | -35.64%-137M | -81M | 86.57%-87M | 111.42%74M | -60M | -101M | 0 |
| Gain(Loss) on derecognition of available-for-sale financial assets | -101M | -31.37%-67M | 50.04%-571M | 73.87%-248M | 36.25%-51M | 0.61%-1.14B | -398.53%-339M | 122.87%225M | -942.86%-949M | -1,042.86%-80M |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -128M | 101.61%5M | -59.95%-627M | 97.17%-9M | -30,900.00%-310M | 89.24%-392M | 103.54%7M | 97.48%-80M | -20.45%-318M | 50.00%-1M |
| Less:Other special charges | ---9M | ---- | 377.14%334M | --9M | 15,400.00%310M | -97.96%70M | -225.00%-5M | -97.70%73M | --0 | 0.00%2M |
| Less:Write off | --137M | ---5M | -9.01%293M | --0 | --0 | 56.31%322M | -101.03%-2M | --7M | 2,550.00%318M | ---1M |
| Other non-operating income (expenses) | 6M | 117.54%10M | 357.14%54M | 2,066.67%59M | -400.00%-57M | 92.13%-21M | 98.37%-5M | -228.00%-32M | 70.00%-3M | -20.83%19M |
| Income before tax | 3.67B | -7.17%3.58B | -40.83%7.54B | -96.93%83M | -0.13%3.85B | 290.27%12.75B | 356.21%2.62B | 273.36%3.57B | 0.97%2.71B | 5.18%3.86B |
| Income tax | 1.03B | -3.29%1.09B | -44.73%2.9B | -2.63%1.37B | -32.33%1.12B | 102.74%5.25B | 205.39%1.53B | 525.00%646M | 45.45%1.41B | 30.79%1.66B |
| Net income | 2.65B | -8.76%2.49B | -38.11%4.65B | -199.15%-1.29B | 24.24%2.73B | 1,003.68%7.51B | 171.59%1.09B | 253.28%2.92B | -24.17%1.3B | -8.39%2.2B |
| Net income continuous operations | --2.65B | -8.76%2.49B | -38.11%4.65B | -199.15%-1.29B | 24.24%2.73B | 1,003.68%7.51B | 171.59%1.09B | 253.28%2.92B | -24.17%1.3B | -8.39%2.2B |
| Noncontrolling interests | -53M | 77.78%-16M | 30.56%-100M | -45.45%-48M | -16.13%-72M | 72.93%-144M | 90.00%-20M | 87.66%-29M | 48.44%-33M | -87.88%-62M |
| Net income attributable to the company | 2.7B | -10.57%2.5B | -37.97%4.75B | -193.31%-1.24B | 24.00%2.8B | 531.11%7.65B | 183.85%1.11B | 276.80%2.95B | -25.06%1.33B | -7.04%2.26B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 2.7B | -10.57%2.5B | -37.97%4.75B | -193.31%-1.24B | 24.00%2.8B | 531.11%7.65B | 183.85%1.11B | 276.80%2.95B | -25.06%1.33B | -7.04%2.26B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 22.87 | -10.54%21.23 | -38.51%40.22 | -194.52%-10.52 | 19.61%23.73 | 513.60%65.41 | 180.02%9.33 | 271.17%25.11 | -28.75%11.13 | -7.16%19.84 |
| Diluted earnings per share | 22.87 | -10.54%21.23 | -38.51%40.22 | -194.58%-10.5264 | 19.61%23.73 | 515.91%65.41 | 180.02%9.33 | 270.37%24.9938 | -28.47%11.13 | -6.77%19.84 |
| Dividend per share | 14.87 | 16.26%13.8 | -16.52%27.38 | -64.91%2 | 17.52%11.87 | 56.19%32.8 | 7.2 | 9.8 | -32.94%5.7 | -19.20%10.1 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |